Bioniche signs agreement for veterinary technology

Bioniche Life Sciences Inc, Belleville ON, has signed an agreement with Trophogen Inc, Rockville MD, to gain commercial access to its proprietary superagonist hormone technology platform. The technology will be developed into a next generation follicle stimulating hormone that will greatly increase receptor binding activity as well as vitro and in vivo potency. The two firms will also work together to co-develop new veterinary products. Bioniche holds an option to license additional veterinary reproductive products using Trophogen's technology….